Open AccessThe Possible Associaton Between Cerebral Venous Thrombosis and COVID-19 Infecton in a Patent WithSickle Cell Disease: A Case Report
Author(s) -
Athena Sharifi Razavi,
Narges Karimi
Publication year - 2021
Publication title -
case reports in clinical practice
Language(s) - English
Resource type - Journals
eISSN - 2538-2691
pISSN - 2538-2683
DOI - 10.18502/crcp.v5is1.6239
Subject(s) - medicine , intracranial thrombosis , venous thrombosis , intracerebral hemorrhage , thrombosis , covid-19 , etiology , stroke (engine) , disease , pediatrics , infectious disease (medical specialty) , mechanical engineering , subarachnoid hemorrhage , engineering
Background: The most common symptom of the novel Coronavirus Disease 2019 (COVID-19) infection is fever and dyspnea that leads to hypoxia in severe cases. Some COVID-19 patients experience neurological symptoms, including ischemic stroke and intracerebral hemorrhage. Sickle Cell Disease (SCD) is a hypercoagulable state, however, it has not been approved as a significant cause of Cerebral Venous Thrombosis (CVT).
Case presentation: In this case report, we described CVT in an SCD patient who had COVID-19, as well. We reported a 32-year-old man with a history of sickle cell anemia presented with left hemiparesis, headache, and seizure. After evaluation of the patient, CVT accompanied by COVID-19 infection was diagnosed. He was treated with intravenous unsaturated heparin, antiepileptic drugs, and antiviral agents with a favorable outcome. Based on our knowledge, this is the first case study to describe an association between CVT and COVID-19 infection in a patient with SCD.
Conclusion: During the recent pandemic, vaso-occlusive attacks in SCD patients can be evaluated for COVID-19 as an etiological factor.